IMMUNOLOGICAL CHARACTERIZATION OF CELLS
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
批准号:
3458730
负责人:
EMMANUEL T. AKPORIAYE
金额:
$8.05万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1993-05-31
关键词:
Porifera T lymphocyte breast neoplasms cell population study cellular immunity cellular oncology chemoattractants chemotaxis gel filtration chromatography gelatin high performance liquid chromatography host neoplasm interaction interleukin 2 laboratory mouse macrophage macrophage activating factor metastasis monoclonal antibody neoplasm /cancer immunology neoplasm /cancer immunotherapy tissue /cell culture
中文摘要
乳头瘤病毒(PV)是一种迷人的病原体,
常见病变包括皮肤、肛门生殖器和宫颈
疣。 人类PV与阴茎、外阴和
宫颈癌
乳头瘤病毒具有相对较小的(8000)碱基对DNA
编码10-12种蛋白质的基因组,
基因调控、DNA复制和致癌
转化。 牛(B)PV是最广泛使用的遗传疫苗。
检查PV功能的模型。 一个单核苷酸酶区域,
BPV含有调节TIS表达的DNA序列,
基因组 沿着几个启动子,该区域包括顺式-
作用增强子,其刺激转录独立于
方向或位置。 这种增强子的激活依赖于
在BPV E2阅读框的基因产物上。 E2已经
显示为序列特异性DNA结合蛋白,识别
所有PV基因组共有的基序。 此处描述的数据
证明增强子活性由E2 DNA提供
与异源启动子和E2基因连接的结合位点
产品
拟议的实验涉及表征的
E2的结构、形式、翻译后状态和稳定性
BPV感染细胞中的蛋白质,
将使用抗体。 E2与其DNA识别的结合
网站将进行研究。 E2的职能组织将是
通过突变分析确定,并将与其
结构、生化特性和反式激活能力。
假设它与细胞因子相互作用,
将检查转录增强。 这些研究将
阐明进一步了解PV基因调控以及
提供了深入了解基因控制的增强子机制。
英文摘要
Papillomaviruses (PVs) are fascinating pathogens that cause many
common lesions including cutaneous, anogenital, and cervical
warts. Human PVs are closely associated with penile, vulvar, and
cervical cancers.
Papillomaviruses have relatively small (8000) base pair DNA
genomes that encode 10-12 proteins and lends itself as a paradigm
of gene regulation, DNA replication, and oncogenic
ransformation. The bovine (B) PV is the most widely used genetic
model for examination of PV functions. A one kilobase region of
BPV contains DNA sequences that regulate expression of tis
genome. Along with several promoters, this region includes a cis-
acting enhancer that stimulates transcription independent of
orientation or position. Activation of this enhancer is dependent
on a gene product of the BPV E2 reading frame. E2 has been
shown to be a sequence-specific DNA binding protein, recognizing
a motif common to all PV genomes. Data described here
demonstrate that enhancer activity is provided by the E2 DNA
binding site linked to a heterologous promoter and the E2 gene
product.
The proposed experiments involve characterization of the
structure, form, post-translational state, and stability of the E2
protein in BPV-infected cells for which polyclonal and monoclonal
antibodies will be used. The binding of E2 to its DNA recognition
site will be studied. The funcitonal organization of E2 will be
determined by mutational analysis and will be correlated with its
structure, biochemical properties, and transactivating capacity.
The hypothesis that it interacts with cellular factors for
transcriptional enhancement will be examined. These studies will
elucidate further understanding of PV gene regulation as well as
provide insights into the enhancer mechanism of gene control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA-Lys in Combination with Trastuzumab Against HER2/neu Positive Breast Cancer
-
批准号:10256181
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
-
批准号:7211835
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2007
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
-
批准号:7630957
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2007
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
-
批准号:7570010
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
-
批准号:7387375
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2007
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
-
批准号:7800437
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2007
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Effect of Tumor Derived TGF B on Dendritic Cell Vaccines
-
批准号:6832832
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2002
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Effect of Tumor Derived TGF B on Dendritic Cell Vaccines
-
批准号:6620924
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2002
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Effect of Tumor Derived TGF B on Dendritic Cell Vaccines
-
批准号:6423615
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2002
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
Effect of Tumor Derived TGF B on Dendritic Cell Vaccines
-
批准号:6706204
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2002
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
LOSS OF TUMORGENICITY INDUCED BY TGF-B ANTISENSE GENE
-
批准号:2700652
-
项目类别:
-
资助金额:$17.52万
-
财政年份:1997
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
LOSS OF TUMORGENICITY INDUCED BY TGF-B ANTISENSE GENE
-
批准号:2895444
-
项目类别:
-
资助金额:$18.04万
-
财政年份:1997
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
LOSS OF TUMORGENICITY INDUCED BY TGF-B ANTISENSE GENE
-
批准号:2009154
-
项目类别:
-
资助金额:$17.43万
-
财政年份:1997
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
-
批准号:3458731
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1988
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
-
批准号:3458734
-
项目类别:
-
资助金额:$1.07万
-
财政年份:1988
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
-
批准号:3458732
-
项目类别:
-
资助金额:$8.02万
-
财政年份:1988
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
-
批准号:3458729
-
项目类别:
-
资助金额:$9.36万
-
财政年份:1988
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
IMMUNOLOGICAL CHARACTERIZATION OF CELLS
-
批准号:3458733
-
项目类别:
-
资助金额:$8.42万
-
财政年份:1988
-
负责人:EMMANUEL T. AKPORIAYE
-
依托单位:
海外基金